Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.

Standard

Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. / Rades, Dirk; Hoskin, Peter J; Stalpers, Lukas J A; Schulte, Rainer; Poortmans, Philip; Veninga, Theo; Dahm-Daphi, Jochen; Obralic, Nermina; Wildfang, Ingeborg; Bahrehmand, Roja; Engenhart-Cabilic, Rita; Schild, Steven E.

In: INT J RADIAT ONCOL, Vol. 64, No. 5, 5, 2006, p. 1452-1457.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rades, D, Hoskin, PJ, Stalpers, LJA, Schulte, R, Poortmans, P, Veninga, T, Dahm-Daphi, J, Obralic, N, Wildfang, I, Bahrehmand, R, Engenhart-Cabilic, R & Schild, SE 2006, 'Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.', INT J RADIAT ONCOL, vol. 64, no. 5, 5, pp. 1452-1457. <http://www.ncbi.nlm.nih.gov/pubmed/16413695?dopt=Citation>

APA

Rades, D., Hoskin, P. J., Stalpers, L. J. A., Schulte, R., Poortmans, P., Veninga, T., Dahm-Daphi, J., Obralic, N., Wildfang, I., Bahrehmand, R., Engenhart-Cabilic, R., & Schild, S. E. (2006). Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. INT J RADIAT ONCOL, 64(5), 1452-1457. [5]. http://www.ncbi.nlm.nih.gov/pubmed/16413695?dopt=Citation

Vancouver

Rades D, Hoskin PJ, Stalpers LJA, Schulte R, Poortmans P, Veninga T et al. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. INT J RADIAT ONCOL. 2006;64(5):1452-1457. 5.

Bibtex

@article{440eda1c60e84f8bacb0a4bb50d530dc,
title = "Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.",
abstract = "PURPOSE: To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients. METHODS AND MATERIALS: Data for 172 myeloma patients irradiated between January 1994 and December 2004 for SCC were retrospectively evaluated. Short-course RT (1 x 8 Gy, 5 x 4 Gy, n = 61) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy, n = 111) were compared for functional outcome up to 24 months after RT. In addition, 10 potential prognostic factors were investigated. RESULTS: Improvement of motor function occurred in 90 patients (52%). Forty-seven percent of nonambulatory patients regained the ability to walk. Functional outcome was significantly influenced by the time of developing motor deficits before RT. Improvement of motor function was more frequent after long-course RT than after short-course RT: 59% vs. 39% (p = 0.10) at 1 month, 67% vs. 43% (p = 0.043) at 6 months, 76% vs. 40% (p = 0.003) at 12 months, 78% vs. 43% (p = 0.07) at 18 months, and 83% v 54% (p = 0.33) at 24 months. A subgroup analysis of the long-course RT group demonstrated a similar functional outcome for 10 x 3 Gy when compared with 15 x 2.5 Gy and 20 x 2 Gy. CONCLUSIONS: Long-course RT is preferable for SCC in myeloma patients because it resulted in better functional outcome than short-course RT. Treatment with 10 x 3 Gy can be considered appropriate.",
author = "Dirk Rades and Hoskin, {Peter J} and Stalpers, {Lukas J A} and Rainer Schulte and Philip Poortmans and Theo Veninga and Jochen Dahm-Daphi and Nermina Obralic and Ingeborg Wildfang and Roja Bahrehmand and Rita Engenhart-Cabilic and Schild, {Steven E}",
year = "2006",
language = "Deutsch",
volume = "64",
pages = "1452--1457",
journal = "INT J RADIAT ONCOL",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.

AU - Rades, Dirk

AU - Hoskin, Peter J

AU - Stalpers, Lukas J A

AU - Schulte, Rainer

AU - Poortmans, Philip

AU - Veninga, Theo

AU - Dahm-Daphi, Jochen

AU - Obralic, Nermina

AU - Wildfang, Ingeborg

AU - Bahrehmand, Roja

AU - Engenhart-Cabilic, Rita

AU - Schild, Steven E

PY - 2006

Y1 - 2006

N2 - PURPOSE: To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients. METHODS AND MATERIALS: Data for 172 myeloma patients irradiated between January 1994 and December 2004 for SCC were retrospectively evaluated. Short-course RT (1 x 8 Gy, 5 x 4 Gy, n = 61) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy, n = 111) were compared for functional outcome up to 24 months after RT. In addition, 10 potential prognostic factors were investigated. RESULTS: Improvement of motor function occurred in 90 patients (52%). Forty-seven percent of nonambulatory patients regained the ability to walk. Functional outcome was significantly influenced by the time of developing motor deficits before RT. Improvement of motor function was more frequent after long-course RT than after short-course RT: 59% vs. 39% (p = 0.10) at 1 month, 67% vs. 43% (p = 0.043) at 6 months, 76% vs. 40% (p = 0.003) at 12 months, 78% vs. 43% (p = 0.07) at 18 months, and 83% v 54% (p = 0.33) at 24 months. A subgroup analysis of the long-course RT group demonstrated a similar functional outcome for 10 x 3 Gy when compared with 15 x 2.5 Gy and 20 x 2 Gy. CONCLUSIONS: Long-course RT is preferable for SCC in myeloma patients because it resulted in better functional outcome than short-course RT. Treatment with 10 x 3 Gy can be considered appropriate.

AB - PURPOSE: To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients. METHODS AND MATERIALS: Data for 172 myeloma patients irradiated between January 1994 and December 2004 for SCC were retrospectively evaluated. Short-course RT (1 x 8 Gy, 5 x 4 Gy, n = 61) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy, n = 111) were compared for functional outcome up to 24 months after RT. In addition, 10 potential prognostic factors were investigated. RESULTS: Improvement of motor function occurred in 90 patients (52%). Forty-seven percent of nonambulatory patients regained the ability to walk. Functional outcome was significantly influenced by the time of developing motor deficits before RT. Improvement of motor function was more frequent after long-course RT than after short-course RT: 59% vs. 39% (p = 0.10) at 1 month, 67% vs. 43% (p = 0.043) at 6 months, 76% vs. 40% (p = 0.003) at 12 months, 78% vs. 43% (p = 0.07) at 18 months, and 83% v 54% (p = 0.33) at 24 months. A subgroup analysis of the long-course RT group demonstrated a similar functional outcome for 10 x 3 Gy when compared with 15 x 2.5 Gy and 20 x 2 Gy. CONCLUSIONS: Long-course RT is preferable for SCC in myeloma patients because it resulted in better functional outcome than short-course RT. Treatment with 10 x 3 Gy can be considered appropriate.

M3 - SCORING: Zeitschriftenaufsatz

VL - 64

SP - 1452

EP - 1457

JO - INT J RADIAT ONCOL

JF - INT J RADIAT ONCOL

SN - 0360-3016

IS - 5

M1 - 5

ER -